The results from screening for the most efficient siRNA sequence to target YAP1 were shown in Figure 3A, siRNA-YAP1-1 exerted the most efficient YAP1 interference in both CD133+CD44+ and CD133-CD44- CRC cells, and it was then used in further experiments. The gene discussed is YAP1; the disease is colorectal carcinoma.